イノベーションに情熱を。ひとに思いやりを。
第一三共株式会社 (Daiichi Sankyo Company, Limited) (daiichisankyo.co.jp) scores 65 out of 100 on Brand Analyzer, placing it in the Developing tier among Healthcare brands, in the 12th percentile of 21637 Healthcare brands.
第一三共株式会社 (Daiichi Sankyo Company, Limited) is a 第一三共株式会社公式ウェブサイト（日本語）です。私たちは、革新的医薬品を継続的に創出し、多様な医療ニーズに応える医薬品を提供することで、世界中の人々の健康で豊かな生活に貢献してまいります。. 革新的医薬品を継続的に創出し、多様な医療ニーズに応える医薬品を提供することで、世界中の人々の健康で豊かな生活に貢献する。.
| Brand Name | 第一三共株式会社 (Daiichi Sankyo Company, Limited) |
|---|---|
| Domain | daiichisankyo.co.jp |
| Industry | Healthcare |
| Main Competitors | Takeda Pharmaceutical (87/100), Astellas Pharma (90/100), Eisai (80/100), Chugai Pharmaceutical (35/100), Otsuka Pharmaceutical (75/100), Shionogi (84/100), Sumitomo Pharma (66/100), AstraZeneca (82/100), Pfizer (89/100) |
Moz Domain Authority 47/100 vs category average 40 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
Ranked #365,816 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "第一三共株式会社公式ウェブサイト（日本語）です。私たちは、革新的医薬品を継続的に創出し、多様な医療ニーズに応える医薬品を提供することで、世界中の人々の健康で豊かな生活に貢献してまいります。" (Meta description too short (1 words). OG description present but brief) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 1 JSON-LD block(s), Organization schema, Breadcrumb/Website schema, og:title, og:description, og:image, og:type, canonical. Adding FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Content is JA-only, limiting citation in English-language AI answers.
Social footprint: verified profiles on X (Twitter), Facebook, Instagram, GitHub; no detected presence on LinkedIn, YouTube - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked October 2026.
When asked "What is 第一三共株式会社 (Daiichi Sankyo Company, Limited)?", Claude could identify the brand as of October 2026. Daiichi Sankyo is a major Japanese pharmaceutical company formed in 2005 through the merger of Daiichi Pharmaceutical and Sankyo Company, focused on prescription drugs including cardiovascular treatments, oncology therapies, and antibody-drug conjugates. It has gained significant Best known for Enhertu, its breakthrough antibody-drug conjugate cancer therapy developed with AstraZeneca.
When asked "Best brands similar to 第一三共株式会社 (Daiichi Sankyo Company, Limited)?", Claude would recommend 第一三共株式会社 (Daiichi Sankyo Company, Limited) as of October 2026. It's a top-tier global pharma player with a cutting-edge oncology pipeline, so it would naturally come up alongside companies like AstraZeneca, Eisai, or Takeda.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
第一三共株式会社 (Daiichi Sankyo Company, Limited)'s main competitors in Healthcare: Takeda Pharmaceutical (87/100), Astellas Pharma (90/100), Eisai (80/100), Chugai Pharmaceutical (35/100), Otsuka Pharmaceutical (75/100).
Sources: Brand Analyzer scan
第一三共株式会社 (Daiichi Sankyo Company, Limited) has limited AI-search visibility, scoring 31/100 on Brand Analyzer's AI visibility composite (visibility 5, trust 55, recommendation 50). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: 第一三共株式会社 (Daiichi Sankyo Company, Limited) official site
第一三共株式会社 (Daiichi Sankyo Company, Limited) scores 50/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: 第一三共株式会社 (Daiichi Sankyo Company, Limited) official site
第一三共株式会社は、日本に拠点を置くグローバル製薬企業であり、革新的な医薬品の研究開発と提供を通じて世界中の人々の健康に貢献することを目的とした企業である。
Sources: 第一三共株式会社 (Daiichi Sankyo Company, Limited) official site
第一三共株式会社 (Daiichi Sankyo Company, Limited) can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: 第一三共株式会社 (Daiichi Sankyo Company, Limited) official site
第一三共の製品やサービスは、患者、医療従事者、株主・投資家、報道関係者など、医薬品および医療情報に関心を持つ国内外のステークホルダーによって利用されている。
Sources: 第一三共株式会社 (Daiichi Sankyo Company, Limited) official site
第一三共株式会社 (Daiichi Sankyo Company, Limited) scores 31/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
第一三共株式会社 (Daiichi Sankyo Company, Limited) has a weak AI-visibility profile at 31/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is trust (55/100) and its weakest is visibility (5/100). It benefits from a global traffic rank of #365,816 (Tranco), a Moz Domain Authority of 47/100 and open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, no strong Wikidata entry and no llms.txt to steer AI to its best pages. In a live check, Claude could already identify 第一三共株式会社 (Daiichi Sankyo Company, Limited) from memory (October 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to 第一三共株式会社 (Daiichi Sankyo Company, Limited): Curve Tomorrow (65/100), Cramer Sports Med (65/100), DesireeAlliance (65/100), DexaBody (65/100).
A step up - brands to learn from: Zentralwohlfahrtsstelle der Juden in Deutschland e.V. (71/100), ZT Corporate (71/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.